3 Biotech Stocks With Major Catalysts in October
Every month brings plenty of catalysts for several biotech stocks. October is no exception. There are quite a few regulatory decisions and clinical results expected to be announced next month.
Three biotechs in particular could enjoy boosts to their stocks if all goes well. Here are the major catalysts that could help -- or possibly hurt -- Alexion Pharmaceuticals (NASDAQ: ALXN), bluebird bio (NASDAQ: BLUE), and Sarepta Therapeutics (NASDAQ: SRPT).
Source: Fool.com